Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals
09. August 2018 16:05 ET
|
Organovo, Inc.
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Lead IND program for Alpha-1-antitrypsin deficiency (“A1AT”) expected to commence IND-enabling...
Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer
01. August 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Steven G. Hughes has been named Chief Medical Officer. Dr. Hughes is an industry...
Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results
19. Juli 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 9, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019
31. Mai 2018 16:05 ET
|
Organovo, Inc.
- Lead Investigational New Drug (“IND”) program for Alpha-1-antitrypsin deficiency (“A1AT”) received FDA’s orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019 -...
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
14. Mai 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, May 31, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress
10. Mai 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present new preclinical data showing the strong functionality of its liver...
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
03. Mai 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has joined a new public-private Manufacturing USA initiative, the Advanced...
Organovo to Present at 2nd Annual NASH Summit
24. April 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, April 24, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April...
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
16. April 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities...
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™
12. April 2018 08:05 ET
|
Organovo, Inc.
SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted...